First‑Line Fecal Microbiota Transplantation Shows Rapid Efficacy in Immune Checkpoint Inhibitor–Induced Colitis

First‑line fecal microbiota transplantation yields rapid improvement in most patients with immune checkpoint inhibitor–mediated colitis. In this cohort, 76.9% responded within a median 1.5 days, with increased microbial diversity and reduced immune‑cell activation after treatment. Multi‑omics profiling highlights potential mechanisms underlying FMT response.


Read full article at:

https://www.sciencedirect.com/science/article/pii/S2666379126004611

#FMT rapidly improves ICI‑induced #colitis. Most patients respond, showing higher microbial diversity & reduced immune activation.



Popular posts from this blog

Salivary microbiome diversity is associated with oral health and disease

Pacific has one of most successful years for grants in school history